Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
Read the official source — NCT01323192Researchers compared JNS001 and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including ChibaAn Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia
Read the official source — NCT00728195This study evaluated the safety and effectiveness of JNJ-37822681 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BurgasAn Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia
Read the official source — NCT01009047A Randomized, Multicenter, Double-Blind, Active-Controlled, Flexible-Dose, Parallel-Group Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Symptoms of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age
This study has finished and is no longer accepting participants.
Multiple locations, including DothanAn Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
Read the official source — NCT00992407A Randomized, Open-label, Active-controlled Study to Evaluate Social Functioning of Long Acting Injectable Risperidone and Oral Risperidone in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In AnsanAn Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Read the official source — NCT00526877This study evaluated the safety and effectiveness of Risperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
In TaipeiAn Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia
Read the official source — NCT00269919Researchers studied Risperidone Long-Acting Injectable (RLAI) to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In SeoulAn Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
Read the official source — NCT00524043Researchers compared Paliperidone ER and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosAn Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
Read the official source — NCT01012622An Open-label Prospective Trial to Evaluate Functional Outcomes of OROS Methylphenidate in Children With ADHD (FOSCO)
This study has finished and is no longer accepting participants.
Location not clearly listedAn Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia
Read the official source — NCT00566631Researchers studied Paliperidone to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including ZagrebAn Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia
Read the official source — NCT01299389Researchers compared Paliperidone palmitate and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including FujiokaAn Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders
Read the official source — NCT01855074This study evaluated the safety and effectiveness of Risperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedA Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a Monoaminergic Antidepressant in Adults With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.